NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lipo-Immuno Tech

Lipo-Immuno Tech

Private
Mount Pleasant, South CarolinaHealthcare & Life Scienceshttps://www.theredpoppyrichmond.com/

Last Round

Accelerator

Apr 10, 2025

Total Funding Raised

$3.02M

Company Overview

Lipo-Immuno Tech is a biotechnology company that develops anti-cancer strategies utilizing lipid metabolism/signaling and immunotherapy, with potential applications for neurodegenerative disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

preclinical biotechcancer immunotherapyoncology therapeuticsadoptive cell therapytumor-infiltrating lymphocytesTILscell therapyacute myeloid leukemiaAMLlipid metabolismsmall molecule therapeuticsdrug discoverymitophagy inductionpyridinium-ceramide compoundsneurodegenerative disease researchuniversity spin-outSTTR grant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lipo-Immuno Tech Comparables

Compare Lipo-Immuno Tech with similar companies based on industry and business-model similarity.

Lipo-Immuno Tech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Lipo-Immuno Tech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorApr 10, 2025
GrantJul 23, 2024
GrantSep 15, 2023
GrantApr 4, 2023
GrantFeb 15, 2020

Lipo-Immuno Tech Investors

Notable investors and investment history

Lipo-Immuno Tech investors
InvestorRounds
National Cancer InstituteGrant
NIH RADxGrant
SCbioDriveAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2025

    Raised an Accelerator round with SCbioDrive as an investor.

  • Jul 23, 2024

    $1M grant awarded by NIH RADx

Lipo-Immuno Tech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lipo-Immuno Tech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lipo-Immuno Tech's valuation, stock price, and market status.

Firmographic Details

HeadquartersMount Pleasant, South Carolina
Year Founded2018
Last FundingApr 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.